Alembic gets FDA OK for generic Vesicare

Press enter to search
Close search
Open Menu

Alembic gets FDA OK for generic Vesicare

By Sandra Levy - 05/24/2019
Alembic has received the Food and Drug Administration’s approval for solifenacin succinate tablets, in 5-mg and 10-mg dosage strengths.

The product is indicated for the treatment of overactive bladder.

It is the generic of Astellas Pharma’s Vesicare tablets.

Solifenacin succinate tablets 5 mg and 10 mg had a market value of approximately $967 million for the 12 months ending December 2018, according to IQVIA.

RELATED TOPICS